ReviewCureus2025
Epidemiology and Risk Factors of Irritable Bowel Syndrome in the Saudi Population: A Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Application of a food trigger score to identify common dietary triggers among Saudi adults with irritable bowel syndrome.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2026Article
- Article
- Association of irritable bowel syndrome with depression, anxiety, stress, and sociodemographic factors in Saudi Arabia: a cross-sectional survey.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This systematic review examines the available literature on the epidemiology and risk factors of irritable bowel syndrome (IBS) in the Saudi population. A comprehensive electronic search of PubMed, SCOPUS, Science Direct, Cochrane Library, and Web of Science was conducted, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines to identify studies assessing IBS prevalence and risk factors in Saudi Arabia. A total of 22 studies involving 20,755 participants met the inclusion criteria. Most studies (21/22) used ROME IV criteria for IBS diagnosis, while one study used a self-administered questionnaire. The reported prevalence of IBS ranged from 2.7% to 83.3%, with an overall prevalence of 26.3% (5461 cases). Significant risk factors for IBS included depression, anxiety, a family history of IBS, female gender, student status, and middle age, while patients with IBS were more likely to exhibit higher levels of anxiety, depression, and nomophobia. Dietary habits also played a role, with the non-IBS group consuming more fiber and niacin, whereas the IBS group consumed more energy and carbohydrates. The findings of this systematic review highlight the substantial burden of IBS in Saudi Arabia and underscore the importance of dietary patterns, psychosocial factors, and genetic predisposition in its onset and severity. Given these insights, public health initiatives should focus on patient education and culturally tailored interventions for the effective management of IBS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.